In the current revascularized CAD cohort with OSA, TNF-α-308G/A gene polymorphism was significantly correlated with the change in circulating TNF-α levels from baseline in response to 12 months of CPAP treatment, independent of age, sex, BMI, baseline AHI, ESS, and diabetes. This evidence concerns the gene TNF and diabetes mellitus.